Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Jul 30, 2026
13 days ago · 100% complete
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Check Point Software Technologies Ltd. (CHKP) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-13): Designation Watch · Cairn score +28 (−100…+100 Quality+Value blend) · Quality 44 · Value 15 · Sentiment -14 (timing only, not weighted) · Composite fair value $184.08 vs $128.22 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Check Point Software Technologies Ltd.

CHKP NASDAQ
Technology · Software - Infrastructure
Tel Aviv, 6789159, Israel checkpoint.com Updated Jul 30, 5:02pm
Price
$128.23
Market Cap
$13.1B
Employees
6,669
Beta
0.49
Avg Volume
1,194,204
CEO
Brig.Gen. Nadav Zafrir

Check Point Software Technologies Ltd. is a global cybersecurity company that develops and markets security software and related services for organizations of all sizes. Headquartered in Tel Aviv, Israel and founded in 1993, the company focuses on protecting enterprise networks, cloud environments, endpoints, emails, and mobile devices against advanced cyber threats. Check Point’s portfolio centers on its Infinity Platform, which integrates network security, cloud security, and workspace security with unified management and a prevention-first approach. Its technologies include next-generation firewalls, intrusion prevention, data loss prevention, secure remote access, and advanced threat prevention tools designed to block malware, ransomware, phishing, and other attacks. The company serves corporate enterprises, service providers, and government agencies across the Americas, Europe, the Middle East, Africa, and Asia-Pacific, distributing solutions primarily through partners such as distributors, value-added resellers, systems integrators, and managed service providers. Check Point Software Technologies Ltd. plays a significant role in the global cybersecurity market by offering consolidated, AI-enhanced defenses and centralized security management across complex hybrid IT infrastructures.

Runs with full report Generated: Jul 30, 2026 5:59pm
Earnings Schedule
Checked daily · calendar updated Aug 13
No upcoming print on the calendar yet — companies typically confirm a few weeks ahead. Last print was Jul 28, 2026.
EPS surprise history — vs analyst consensus · 3 prints of vendor history
+93.4%
Feb '26
+4.2%
Apr '26
+1.4%
Jul '26
Print date EPS est. EPS actual Revenue est. Revenue actual
Jul 28, 2026 $2.80 $2.84 +1.4%
Apr 30, 2026 $2.40 $2.50 +4.2%
Feb 6, 2026 $3.18 $6.15 +93.4%

Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.

Recent SEC Filings
Filed Form Document
Aug 12, 2026 SCHEDULE 13G/A View
Aug 6, 2026 4 View
Aug 4, 2026 144 View
Aug 4, 2026 4 View
Aug 4, 2026 4 View
Aug 4, 2026 144 View
Aug 4, 2026 144 View
Aug 4, 2026 144 View
Aug 4, 2026 144 View
Aug 4, 2026 144 View
Aug 4, 2026 144 View
Aug 3, 2026 4 View

Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.

Price Overview
Price at report time
$128.22
as of Jul 30, 5:53pm (13d ago)
Change · Jul 30
-11.45 (-8.20%)
Day Range
$122.18 – $128.85
52-Week Range
$112.23 – $210.66
50-Day MA
$131.11
200-Day MA
$159.33
Volume
4,249,157.00
Right now · live
loading…
 
Real-time — the change above is the move since the report (over 13d).
Share Structure
Outstanding 104,027,807.00
Float 79,073,628.00
Free Float 76.0%
Normal free float — 76.0% of shares trade freely, ~24% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Last updated: Jul 30, 2026 6:06pm (13d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jul 30, 2026 5:53pm (13d ago)
Why there are no quarterly figures for Check Point Software Technologies Ltd.

Check Point Software Technologies Ltd. is a foreign private issuer — it reports to the U.S. SEC once a year (on Form 20-F or 40-F) rather than filing the quarterly statements (10-Q) that U.S.-domiciled companies must submit. Our financial statements are read directly from SEC filings, so for this company only annual figures exist at the source.

This is a property of how the company files, not missing or broken data — its filing history shows 16 annual reports, the latest filed 2026-03-31, and no quarterly filings . The company may still publish quarterly results on its own investor-relations site.

Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Jul 30, 2026 5:59pm
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
13.33
Stock Price: $128.23
EPS (Diluted): 9.62
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
4.89
Stock Price: $128.23
Total Equity: $2.88B
Shares: 109,913,789
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
13.19
Market Cap: $13.09B
Total Debt: $0.00
Cash: $1.80B
EBITDA: $855.90M
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$11.3B
Market Cap: $13.09B
Total Debt: $0.00
Cash: $1.80B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
86.7%
Gross Profit: $2.36B
Revenue: $2.73B
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
30.5%
Operating Income: $831.10M
Revenue: $2.73B
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
38.8%
Net Income: $1.06B
Revenue: $2.73B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
36.7%
Net Income: $1.06B
Total Equity: $2.88B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
85.9%
Operating Income: $831.10M
Tax Rate: -11.8%
Equity: $2.88B
Total Debt: $0.00
Cash: $1.80B
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
2.05
Current Assets: $3.96B
Current Liabilities: $1.94B
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.88B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$24.80
Revenue: $2.73B
Shares: 109,913,789
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$26.22
Total Equity: $2.88B
Shares: 109,913,789
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$10.67
Operating CF: $1.20B
CapEx: -$26.60M
Shares: 109,913,789
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
Last Dividend: $0.00
Stock Price: $128.23
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $1.06B
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jul 30, 2026 5:59pm
Compares CHKP against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Jul 30, 2026 5:53pm (13d ago)
Metric 2021 2022 2023 2024 2025
Revenue $2.2B $2.3B $2.4B $2.6B $2.7B
Cost of Revenue $258.1M $304.4M $282.6M $319.3M $361.8M
Gross Profit $1.9B $2.0B $2.1B $2.2B $2.4B
Operating Expenses $1.0B $1.1B $1.2B $1.4B $1.5B
Operating Income $907.5M $884.3M $899.1M $876.0M $831.1M
Net Income $815.6M $796.9M $840.3M $845.7M $1.1B
EBITDA $928.1M $907.0M $922.2M $900.0M $855.9M
EPS $6.13 $6.37 $7.19 $7.65 $9.85
EPS (Diluted) $6.08 $6.31 $7.10 $7.46 $9.62
Balance Sheet (Annual)
Last updated: Jul 30, 2026 5:53pm (13d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $271.9M $196.0M $537.7M $506.2M $1.8B
Total Current Assets $2.3B $2.3B $2.3B $2.2B $4.0B
Total Assets $5.9B $5.7B $5.7B $5.8B $7.8B
Current Liabilities $1.7B $1.8B $1.9B $1.9B $1.9B
Long-Term Debt
Total Liabilities $2.6B $2.8B $2.9B $3.0B $4.9B
Total Equity $3.3B $2.9B $2.8B $2.8B $2.9B
Retained Earnings $11.5B $12.3B $13.2B $14.0B $15.1B
Cash Flow (Annual)
Last updated: Jul 30, 2026 5:53pm (13d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $1.2B $1.1B $1.0B $1.1B $1.2B
Capital Expenditure -$15.9M -$22.1M -$18.6M -$24.2M -$26.6M
Free Cash Flow $1.2B $1.1B $1.0B $1.0B $1.2B
Acquisitions (net) -$219.7M -$48.3M -$458.8M -$185.8M -$273.1M
Net Debt Issued / (Repaid)
Dividends Paid
Stock Buybacks -$1.3B -$1.3B -$1.3B -$1.3B -$1.4B
Net Change in Cash $16.2M -$75.9M $341.7M -$31.5M $1.3B
Growth Trends (YoY %)
Last updated: Jul 30, 2026 5:53pm (13d ago)
Metric 2022 2023 2024 2025
Revenue Growth +7.5% +3.6% +6.2% +6.3%
Gross Profit Growth +6.1% +5.3% +5.3% +5.3%
Operating Income Growth -2.6% +1.7% -2.6% -5.1%
Net Income Growth -2.3% +5.4% +0.6% +25.0%
EBITDA Growth -2.3% +1.7% -2.4% -4.9%
Insider Trading (Recent)
Last updated: Jul 30, 2026 6:01pm (13d ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-08-04 Seddik Sherif S-Sale 10,272.00 $123.59 $1.3M
2026-08-03 Golan Roei S-Sale 409.00 $123.50 $50,510
2026-08-03 Golan Roei S-Sale 9,451.00 $123.76 $1.2M
2026-08-03 Kremer Nataly S-Sale 665.00 $123.64 $82,222
2026-07-31 SHWED GIL J-Other 17.00 $108.06 $1,837
2026-07-31 Zafrir Nadiv J-Other 956.00 $108.06 $103,306
2026-07-31 Seddik Sherif J-Other 801.00 $108.06 $86,556
2026-07-31 Golan Roei J-Other 409.00 $108.06 $44,197
2026-07-31 Kremer Nataly J-Other 665.00 $108.06 $71,860
2026-07-27 Golan Roei A-Award 282.00
2026-07-10 Seddik Sherif A-Award 6,147.00 $0.00 $0
2026-07-10 Seddik Sherif F-InKind 1,536.00 $131.70 $202,291
2026-07-10 Seddik Sherif F-InKind 770.00 $131.70 $101,409
2026-06-11 Shavit Shenhav Tal S-Sale 25,000.00 $123.07 $3.1M
2026-06-11 Shavit Shenhav Tal M-OptionExercise 25,000.00 $114.23 $2.9M
2026-06-11 UNGERMAN JERRY T S-Sale 25,000.00 $122.55 $3.1M
2026-06-11 UNGERMAN JERRY T M-OptionExercise 25,000.00 $114.23 $2.9M
2026-06-02 Chelouche Yoav S-Sale 25,000.00 $140.28 $3.5M
2026-06-02 Chelouche Yoav M-OptionExercise 25,000.00 $114.23 $2.9M
2026-05-26 SHWED GIL G-Gift 3,000.00
Deep Analysis
Last run: Jul 31, 2026 1:12:45 pm

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for Mature Earner companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for Mature Earner companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for Mature Earner companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for Mature Earner companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for Mature Earner companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for Mature Earner companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CHKP — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-07-30 18:05:03
Verdict I partially agree with the synthesis direction but strongly dissent on magnitude. The stock is modestly undervalued as a cash-return vehicle, not deeply undervalued as a re-rating candidate. Fair value $150–160 based on 15x $1.06B NI plus net cash, implying ~20% upside — respectable but not the 84% the composite claims. The re-rating catalyst (Infinity Platform traction) has been promised for years without delivery; betting on it is a hope trade. This is a hold-for-yield-and-buybacks name, not a table-pounder. New CEO Nadav Zafrir (took over early 2024) is the wildcard — if he can arrest margin compression by 2026-2027, the bull case activates; if 2026 operating margin prints below 30%, cut and move on. I'd own it here for the FCF yield with the understanding that multiple expansion is a bonus, not the thesis.

Starting from the raw numbers: CHKP grew revenue from $2.17B (2021) to $2.73B (2025), a 5.9% CAGR — not "declining legacy vendor" territory, but nowhere near PANW/FTNT growth. What's more interesting is the operating income line: $907M in 2021, $831M in 2025. Operating margin compressed from 41.8% to 30.5% over four years. That's the actual story the synthesis engine is glossing over. Net income rose to $1.06B in 2025 but that's flattered by non-operating items (likely interest on the $1.8B cash pile plus tax) — operating earnings actually went backwards while revenue grew 26% cumulative. This is textbook "buying growth by spending on S&M/R&D to defend share," and it's why the market gives it 13x earnings instead of 30x. ROIC of 86% and ROE of 37% are real, but they're the trailing artifact of a capital-light legacy business, not evidence of reinvestment runway.

The synthesis verdict of $184–236 fair value vs $128 (+84%) is aggressive to the point of being unhelpful. A DCF that spits out $184 is implicitly assuming either (a) margin recovery back toward 40%+ or (b) growth acceleration — neither of which the four-year trajectory supports. FCF of $1.17B on a $13.1B market cap is a 8.9% FCF yield, which is genuinely cheap for a software business with no debt and $1.8B cash (EV ~$11.3B, so 10.4% FCF/EV yield). That's the real bull case, and it's more modest than the synthesis claims. A fair multiple for a 6% grower with compressing margins and durable FCF is probably 15–17x earnings, or roughly $145–165 — call it 15–25% upside, not 84%. The narrative model gets this right ("anchored, steady-compounder, minimal intensity"); the synthesis DCF is the outlier.

The contrarian case against even the modest bull thesis: margin compression is not random noise, it's the cost of standing still in a market where PANW and CRWD are compounding revenue at 15–25%. If CHKP has to keep spending to hold 6% growth, operating margins keep drifting toward 25% and the FCF conversion story cracks. The insider activity — repeated 25,000-share option exercise + immediate sale pairings in May/June 2026 — is not a smoking gun but it's not "neutral" either; it's programmatic monetization, not accumulation, and there are zero open-market buys. Also worth flagging: the data file shows 2026-dated insider transactions and a 2025 annual, which means we're looking at reasonably fresh data but the quarterly trajectory is missing entirely ("insufficient_data" on quarterly trend is a real gap — we can't see if Q2/Q3 2026 growth is decelerating). The macro headwinds tag matters here: enterprise security budgets are being scrutinized, and CHKP's exposure to Israeli operations adds a geopolitical discount that no model is quantifying.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-07-30 18:05:21
Verdict Undervalued at $128 — this is a high-margin, net-cash cyber franchise priced like a no-growth legacy asset; fair value looks closer to $155-$170 if revenue holds ~6% and FCF stays above $1.1B.

What stands out is how much of Check Point’s “cheapness” is real cash economics rather than accounting optics. At $128.23, the equity is worth $13.1B, but with $1.8B of cash and no debt, enterprise value is closer to $11.3B. Against 2025 revenue of $2.73B, that is only 4.1x EV/sales; against $1.17B of free cash flow, it is about 9.7x EV/FCF. For a software infrastructure company with 86.7% gross margin, 30.5% operating margin, and 42.9% FCF margin, that is plainly inexpensive. Even the earnings line, which can be noisy, looks supportive: net income jumped from $845.7M in 2024 to $1.06B in 2025, putting the stock at roughly 12-13x trailing earnings. The core story in the numbers is not “broken business,” but “mature franchise producing elite cash while growing just enough.”

The second thing that jumps out is that the market is still treating Check Point as if growth is stuck near stall speed, yet the recent annual progression is better than that caricature. Revenue has moved from $2.17B in 2021 to $2.73B in 2025, a 6.2% CAGR, while free cash flow reached $1.17B on just $26.6M of capex. This is not a transition story burning capital to maybe earn later; it is a finished software model throwing off cash today. Yes, operating income fell from $907.5M in 2021 to $831.1M in 2025, so there is some evidence of reinvestment or pricing pressure, but the decline is modest relative to the revenue gain, and net income actually inflected sharply higher in 2025. That combination—slower operating margin, higher net income, massive cash conversion—suggests the business has enough resilience that the current multiple already discounts a harsher competitive outcome than the reported results show.

I also don’t buy the idea that the low multiple is fully explained by “legacy vendor” status. Plenty of legacy software names deserve low teens earnings multiples because they are ex-growth and financially engineered. Check Point is different because the balance sheet is fortress-like and the cash generation is not synthetic. ROE of 36.7% is high even before considering the net-cash balance sheet, and ROIC near 85.9%—even allowing for metric distortion from the capital-light model—points to a business with unusual economic efficiency. If this were shrinking, I’d understand the discount. But 2025 revenue grew 6.3% and earnings 25%. The valuation synthesis calling for dramatic upside may be too aggressive, but the market’s current price still looks anchored to an outdated view of the company as a no-growth annuity. A fairer range is not peer-multiple euphoria, but something like 15-17x earnings or 11-13x EV/FCF, which would support a stock in roughly the $150-$170 area.

The best case against this view is that the market is correctly looking through today’s margins and cash flow because the strategic position is weaker than the backward-looking numbers imply. Revenue growth of 6% is acceptable, but not strong for cybersecurity, and the more telling warning sign is that operating income in 2025 remains below 2021 despite an extra $560M of revenue. That means incremental margins have been poor, which is exactly what you’d expect if Check Point is spending harder just to defend relevance against faster platforms. The valuation can stay cheap for years if investors believe 2025’s 25% earnings jump is non-repeatable, helped by below-the-line factors rather than a durable acceleration in the core business. The insider tape is not a positive either: mostly option exercises and associated sales, nothing that signals conviction at these levels.

What would change my mind is straightforward. If the next set of annual numbers shows revenue slipping back toward 3-4% growth while operating income stays flat-to-down from the current $831M, then the low multiple is not a mispricing but a value trap on a slowly eroding franchise. Conversely, if Check Point can put up another year near or above $2.9B of revenue, keep FCF around or above $1.1B, and show that operating profit can resume growth instead of just cash flow holding the line, then the stock should not trade at 4.1x EV/revenue and sub-10x EV/FCF. That is the key debate: whether 2025 was a one-year earnings pop on a mature base, or proof the business can still compound. I lean to the latter, enough to say the current discount has overshot the risk.

Grok Reading
Independent reading · grok-4.5 · generated 2026-07-30 18:05:54
Verdict Undervalued cash compounder at $128; 9% FCF yield and fortress BS justify $160-180 even without re-acceleration

Check Point’s numbers describe a capital-light cash machine that is quietly losing operating leverage even as the top line grinds higher. Revenue has compounded at roughly 6% from $2.17B in 2021 to $2.73B in 2025, yet operating income has slipped from $907M to $831M over the same stretch—operating margin compressing from the low-40s toward 30.5%. Net income’s 25% jump to $1.06B in 2025 and the 12% earnings CAGR therefore look more like tax or non-operating noise than genuine operating momentum. What is unambiguous is the cash: $1.20B of operating cash flow and $1.17B of free cash flow against a $13.1B market cap produces a ~9% FCF yield, with essentially zero debt and $1.80B of cash on the balance sheet. Gross margins remain elite at 86.7%, ROIC prints an almost absurd 86%, and the company needs only $27M of capex to sustain the franchise. At 13.3x earnings, 4.1x EV/revenue and 13.2x EV/EBITDA, the market is pricing CHKP as a melting ice cube rather than a durable high-teens-ROE compounder still growing mid-single digits.

The story the raw data tells is therefore not collapse but slow competitive attrition: Check Point is still collecting tolls on a large installed base, converting them into cash at exceptional rates, and returning or accumulating that cash with fortress-like discipline. The valuation synthesis fair-value range of $184–$236 implies 40–80% upside from $128, which is aggressive but directionally consistent with a business that should not trade at half the multiple of peers when it still generates more free cash per dollar of sales than most of them. Insider activity is noise—routine option exercises and sales—rather than a signal of impending deterioration. The contradiction worth catching is between the clean balance-sheet and FCF picture that quantitative screens love, and the five-year erosion in absolute operating profit that those same screens under-weight.

The strongest counter-argument is precisely that operating-income decline and the market’s refusal to re-rate. A smart skeptic would note that revenue growth has never reaccelerated despite years of Infinity Platform promises, that peers with superior growth trajectories command 30–40x earnings for a reason, and that a 13x multiple already embeds the correct terminal-growth assumption of low-single digits plus continued share loss to cloud-native platforms. They would also flag that the 2025 net-income spike looks optically flattering relative to the softer operating line, and that any multiple expansion requires proof the company can stop the margin bleed—proof that has been absent for half a decade. I weigh this less heavily because even a perpetual 5–6% grower with 35%+ net margins, zero leverage and 9% FCF yield is worth more than 13x; the discount already prices in a fair amount of permanent impairment.

What would flip the view is two consecutive quarters of operating-margin expansion back above 33–34% alongside billings or calculated current RPO growth sustainably above 8%, or conversely a further drop in operating income below $800M that confirms structural decay rather than cyclical investment.

Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 8.7; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 8.0
undervalued · conviction 3/5 · Δ -0.7 vs panel · self: 6.0
GPT gpt-5.4 9.0
undervalued · conviction 4/5 · Δ +0.3 vs panel · self: 7.0
Grok grok-4.5 9.0
undervalued · conviction 4/5 · Δ +0.3 vs panel · self: 7.0
Second-round check hasn't run yet for this ticker — it runs after all three seats on the next report.
Advanced Analysis Forensic deep-dive · four lenses
Four separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), General Sentiment (how macro + narrative are pushing it), and AI Impact (how the AI wave reshapes it), kept deliberately apart · 2026-07-30 18:32:33
Delvantic - Cairn AI
Quality-and-cheap-ish — starter here, add under $115 6/10
Quality is real and price is fair-ish, but with no narrative bid and margins still compressing, this is a patient starter, not a table-pound — accumulate under $115.
The cruxWhether new-CEO Zafrir can arrest the 1140bps operating-margin slide by 2026; everything else (cash, buybacks, EPV floor) just buys time for that answer.
Forensic checks Derived mechanically from CHKP's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionShare Count Shrinking
Earnings QualityHigh Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+44
Strong
edge √Σ 126 · risk √Σ 79 · conf 8/10

Check Point runs a fortress-style balance sheet: $1.80B liquid cash, zero debt drag, and $1.17B of annual FCF against a mature security-software base. Earnings quality is unambiguously clean - OCF/NI of 1.29x, accruals at -4.2% of assets, Beneish M of -2.68, Altman Z of 5.31. Capital return is disciplined: diluted shares fell from 134.1M (2021) to 109.9M (2025), a -4.9% CAGR, with buybacks running 8.75x SBC, so the 7.5% SBC/revenue is more than absorbed. Per-share value is being concentrated, not leaked. Revenue growth is steady but modest: $2.17B to $2.73B over four years, roughly 6% CAGR - respectable for a mature security vendor but not a share-taker's trajectory. The real concern is margin drift: operating margin has slid every year from 41.9% (2021) to 38.0%, 37.2%, 34.2%, and now 30.5% - a cumulative ~1140 bps of compression while gross margin held near 87%. That points to opex growth (likely GTM/R&D catch-up against Palo Alto/CRWD/ZS) outrunning revenue. Net income jumped to $1.06B in 2025 largely on non-operating items, since operating margin fell further; investors should verify the mix. Insider tape is neutral-to-mild-negative: three option-exercise-and-sell events (~$9.7M) and a gift by founder Shwed, but no open-market buys. Normal for a mature Israeli tech founder-led firm, not a red flag.

Strengths 3
m78
Fortress balance sheet, fully self-funding
$1.80B net cash (13.8% of mkt cap), zero debt reliance, $1.17B annual FCF. Altman Z 5.31 safe zone. Survival math is trivially solved.
m72
Genuine per-share concentration
Diluted shares -4.9% CAGR (134.1M to 109.9M). Buyback-to-SBC 875%, so 7.5% SBC/rev is more than neutralized. Rare discipline.
m68
Clean earnings quality
OCF/NI 1.29x, accruals -4.2% of assets, Beneish M -2.68. Cash conversion validates reported profits - no aggressive accrual games.
Concerns 3
m62
Operating margin erosion
Op margin fell every year: 41.9% to 38.0% to 37.2% to 34.2% to 30.5% - ~1140 bps of compression while GM held at ~87%. Signals opex outrunning revenue, likely GTM/R&D catch-up vs faster-growing security peers.
m40
Mature growth profile
Revenue CAGR ~6% (2.17B to 2.73B). Adequate but underperforming security-industry growth; hints at share loss in a growing category.
m28
2025 net income jump vs falling op margin
Net income rose to $1.06B while operating margin fell to 30.5%, implying meaningful non-operating contribution. Investors should verify recurrence.
This is a high-integrity, cash-rich mature earner that treats shareholders well - the numbers are real, dilution is negative, and the balance sheet is a fortress. But I cannot ignore that operating margin has fallen every single year since 2021, from 42% to 30%, while competitors in security are compounding revenue at 20%+. That is the fingerprint of a franchise defending its base by spending more, not a franchise pressing an advantage. Quality is Strong, not Fortress - Check Point is durable and disciplined, but the operating trajectory has softened enough that I would not push it into the top decile of public businesses.
Verify before trusting this (6)
  • Composition of 2025 net income - how much came from interest/FX/other non-operating vs operations
  • Segment/product mix trends: is Harmony/CloudGuard actually accelerating or is legacy Quantum firewall carrying revenue?
  • Opex breakdown - is S&M or R&D driving the op-margin compression, and is there a stated reinvestment plan?
  • Customer concentration and net revenue retention disclosures
  • Details of buyback authorization remaining and pace
  • Whether new CEO Nadav Zafrir era brings changed capital allocation or reinvestment posture
Valuation / Mispricing
+15
Modestly Cheap
edge √Σ 79 · risk √Σ 64 · conf 6/10
Price $128 vs my deserved ~$150-160; ~15-20% discount - modest margin of safety, not a table-pounder. attractive below $115.00

The e2e composite pins fair value at $184 and signal-adjusted at $236, implying 44-84% upside. I discount that hard: the DCF at $219 embeds growth optimism that clashes with the actual trend of operating margin falling from 42% to 30% since 2021 and revenue growth in the high single digits, not 20%+. The EPV floor at $113 is more honest for a business whose franchise is quietly eroding at the margin line. Splitting the difference and adjusting up for genuinely high earnings quality, a fortress balance sheet, and negative dilution, I anchor deserved value around $150-160.

Cheap signals 3
m55
Trades below sanity-adjusted deserved value
At $128 vs a deserved band of $150-160 (haircut from the $184 composite for margin erosion), there is a real ~15-20% gap backed by high earnings quality.
m45
Fortress balance sheet not fully credited
Cash-rich, self-funding, negative dilution - the EPV floor at $113 is essentially a downside anchor, meaning downside from $128 is limited.
m35
High earnings quality means no haircut
Earnings-quality score of 3 (High) means reported profits are real - the deserved value does not need to be marked down for accounting aggression or dilution.
Rich / priced-in 2
m50
DCF and signal-adjusted FV look runaway
The $219 DCF and $236 signal-adjusted FV imply growth/margin trajectories that contradict the observed margin decline from 42% to 30% - I discount these heavily.
m40
Deceleration already priced as a discount, not a bargain
The market knows margins are eroding and growth trails peers at 20%+; the current multiple already reflects that, so the 'cheap on peers' argument is weaker than it looks.
Modestly cheap, not a fat pitch. I get a real but limited ~15-20% discount to what this fortress-balance-sheet compounder deserves, and the EPV floor near $113 limits my downside. But the composite FV and DCF are running hot given a business whose margins have compressed 12 points in three years - I do not trust the 84% upside number. I would get genuinely interested below $115 where the EPV floor and margin of safety converge; at $128 it is a hold-and-monitor, not a buy-with-conviction.
Verify before trusting this (4)
  • Infinity Platform ARR growth and attach rates in latest transcript
  • Operating margin trajectory - is the 30% level stabilizing or still falling
  • Buyback pace and remaining authorization (negative dilution is a real value driver)
  • Segment detail on subscription/SaaS mix vs legacy product revenue
General Sentiment
-14
Balanced
tail √Σ 56 · head √Σ 70 · conf 6/10

CHKP sits in an unusual sentiment pocket: the tape is stressed (VIX in the 97th percentile, S&P off its highs, macro headwind from 4.61% 10y and a 26x market PE), but with beta 0.49 and a profitable, cash-generative security incumbent profile, the macro press lands softly on this name. It is neither a high-multiple AI beneficiary being rerated up nor a speculative unprofitable name getting mauled down. The narrative is explicitly minimal intensity, moderate durability, low cult - which is exactly why sentiment is not doing much work here in either direction. Q2 just printed in-line with an EPS beat and guidance maintained, which is a non-event for a steady-compounder story: no fresh fuel, no fresh crack. The AI Network Firewall launch is a modest narrative nudge - it lets CHKP participate in the AI-cyber tape that is lifting CRWD and peers, but the market still treats CHKP as the legacy value name in the group, not the AI winner. The April guide-cut memory (-14.8%) and the unexplained -3.5% drop on 7/21 hint at a lingering slow-drip skepticism rather than active selling. Net: sentiment pressure is close to neutral with a mild negative tilt from sector-relative narrative disadvantage versus CRWD/PANW, offset by defensive beta in a risk-off tape.

Tailwinds 3
m38
Low beta cushions the risk-off tape
Beta 0.49 in a VIX-20.7, stress-negative regime means the macro headwind that is pressing high-multiple software gets absorbed here. Defensive profile is a relative tailwind when the tape is bleeding.
m30
In-line Q2 removes an overhang
EPS beat by 4%, revenue in-line, guidance maintained - after the April guide-cut trauma, simply not stumbling is a small positive sentiment reset.
m28
AI Network Firewall gives a narrative hook
Launching an AI-branded product lets CHKP tag onto the AI-cyber tailwind lifting the sector, even if the market has not repriced it as an AI winner yet.
Headwinds 4
m45
Narrative disadvantage vs CRWD/PANW
The tape is rewarding the AI-threat-wave story owned by CrowdStrike and platform-consolidation owned by Palo Alto. CHKP is framed as the legacy value laggard - moderate but persistent relative-sentiment drag.
m35
Minimal narrative intensity means no bid
Steady-compounder archetype with minimal intensity and low cult means there is no story-driven buyer showing up on dips. The stock drifts on flow, not conviction.
m32
Macro rate/PE backdrop
4.61% 10y and a 26x market PE cap multiple expansion across software. For a name whose bull case requires a rerating, that is exactly the wrong tape.
m25
Residual April guide-cut scar
The -14.8% April sell-off on cut guidance and the unexplained -3.5% on 7/21 suggest investors are quick to sell first, ask later on any whiff of growth slippage.
Net pressure is close to flat with a small negative tilt. The macro tape is hostile to software broadly but this specific name - low beta, profitable, boring - barely feels it, and the in-line print plus AI firewall launch remove near-term downside catalysts. The real drag is not macro, it is narrative starvation: CHKP is the wrong ticker for the story the cyber tape wants to tell right now, so it lacks a marginal buyer even when the fundamentals cooperate. I would call this Balanced leaning mildly headwind - the kind of setup where the stock drifts sideways until either a sector rotation or a fundamental acceleration gives sentiment something to grab.
Verify before trusting this (4)
  • Whether AI Network Firewall gets analyst upgrades or price-target revisions that pull CHKP into the AI-cyber narrative basket
  • Sector rotation signals - if CRWD/PANW stall and money rotates to value-cyber, CHKP is the obvious beneficiary
  • Any subscription revenue acceleration in the next print that would validate the Infinity consolidation story and lift narrative intensity
  • Whether the risk-off regime deepens (VIX >25) - defensive-beta software historically outperforms in that scenario
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
AI Impact
not run

This lens hasn't been run for this ticker yet.

The structural effect of the AI wave on this specific business over the next ~5 years — demand, cost leverage, moat, barriers to entry, position in the AI stack. The reality beneath the AI story, not the story's market pressure (General Sentiment owns that) — and not a call on the business today or the price.
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Four lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and AI Impact (structural ~5yr AI exposure). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Community AI Feedback
No community reviews yet for CHKP. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · twelvedata
v1.1.530 · 761561a2 · 2026-08-12 19:06:35